M&A / Deals Daiichi Sankyo and Interna partner for MNM-targeted delivery solutions Pharmaceutical TechnologyDaiichi Sankyo has partnered with Interna Therapeutics to develop targeted delivery solutions based on molecular nano motor (MNM) technology.M&A / DealsRead full story pharminent April 17, 2026 (Last updated: April 17, 2026) Pharmaceutical Technology Daiichi Sankyo has partnered with Interna Therapeutics to develop targeted delivery solutions based on molecular nano motor (MNM) technology. M&A / DealsRead full story Post navigation Previous: Erica Schwartz, ex-deputy surgeon general, picked to be next CDC directorNext: Trump names Erica Schwartz to fill leadership void at CDC Related Stories M&A / Deals BioMarin spends up to $490m for Alesta’s bone disease candidate pharminent August 19, 2026 M&A / Deals J&J hands lymphoma bispecific CAR T back to AbelZeta pharminent August 17, 2026 M&A / Deals Novo Nordisk and AWS form AI partnership to speed drug discovery pharminent August 17, 2026
